Ritalin vs Vyvanse: How Clinicians Choose ADHD Medications
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
Why is one patient prescribed Ritalin while another receives Vyvanse? Is one medication “stronger” than the other? Does it mean their ADHD is more severe?
In this episode of PoP Pod, we explore the clinical reasoning behind ADHD medication selection and explain why there is no one-size-fits-all approach.
You’ll learn how clinicians individualise treatment by considering factors such as symptom profile, age, daily routine, duration of symptom control required, co-existing medical conditions, previous treatment response, side effects and patient preferences. We’ll also discuss why medication choice is a shared decision-making process and why finding the right treatment sometimes involves careful adjustment over time.
Whether you’re a pharmacy student, pharmacist, doctor or another clinician who works with medicines, this episode will give you a practical framework for understanding how ADHD medications are chosen, and why two patients with the same diagnosis may receive completely different treatments.
Learning objectives
By the end of this episode, you should be able to:
- Explain why ADHD medication selection is not based on the “severity” of ADHD alone.
- Describe the key factors clinicians consider when choosing an ADHD medication.
- Understand the importance of individualising treatment to suit the patient’s needs, lifestyle and goals.
- Recognise the role of shared decision making in ADHD management.
- Appreciate the importance of considering a patient’s complete medication history, including over-the-counter and complementary medicines, when reviewing ADHD treatment.
As always, we’ll finish with reflective CPD questions to help translate today’s learning into your own clinical practice.